US Broker Ratings

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: High Growth Potential Despite Challenges

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) stands at an intriguing juncture for investors, offering a compelling mix of high growth potential and notable risks. With a market capitalization of $1.54 billion,..

CONMED Corporation (CNMD): Investor Outlook on Valuation and Growth Potential with a 24.71% Upside

CONMED Corporation (NASDAQ: CNMD), a prominent player in the healthcare sector, specifically within the medical devices industry, is gaining significant attention from investors due to its promising growth potential and..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Biotechnology Innovator with Over 105% Upside Potential

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage biopharmaceutical company, is capturing investor attention with its innovative approach to addressing chronic diseases through novel oral small molecule therapeutics. Headquartered in South..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Navigating Growth Amid Healthcare Challenges

Pediatrix Medical Group, Inc. (NYSE: MD), operating within the healthcare sector and specializing in medical care facilities, presents a compelling case for investors seeking exposure to the U.S. healthcare market...

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 34.38% Potential Upside in the Healthcare Sector

AdaptHealth Corp. (NASDAQ: AHCO), a key player in the healthcare sector, specializes in the distribution of home medical equipment and services across the United States. With a current market capitalization..

Schrodinger, Inc. (SDGR) Stock Analysis: A 59% Upside Potential in the Cutting-Edge Healthcare Sector

Schrodinger, Inc. (NASDAQ: SDGR) is making waves in the healthcare sector with its innovative approach to drug development and materials science. With a market capitalization of $1.26 billion, this New..

Apogee Therapeutics (APGE) Stock Analysis: Unveiling a 42% Potential Upside

Apogee Therapeutics, Inc. (NASDAQ: APGE) is catching the eye of investors with a compelling opportunity for growth in the biotechnology sector. As a clinical-stage company, Apogee focuses on developing novel..

Azenta, Inc. (AZTA) Stock Analysis: Is There a 2.45% Upside for Investors?

Azenta, Inc. (NASDAQ: AZTA) navigates the dynamic landscape of the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $1.68 billion, Azenta is a..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a Potential 51% Upside with Strategic Partnerships

Innoviva, Inc. (NASDAQ: INVA), a key player in the biotechnology sector, has caught the attention of investors with its recent price activity and strategic collaborations. As of the latest trading..

Perrigo Company plc (PRGO) Stock Analysis: Unpacking a Potential 69% Upside in the Healthcare Sector

Perrigo Company plc (PRGO), a notable player in the healthcare sector, stands at an intriguing juncture for investors. With its headquarters in Dublin, Ireland, Perrigo operates internationally through its Consumer..

10x Genomics, Inc. (TXG) Stock Analysis: A Healthcare Innovator with Mixed Outlooks Amidst Analyst Ratings

10x Genomics, Inc. (NASDAQ: TXG), a prominent player in the healthcare sector, is making waves with its innovative life science technology products. Known for its cutting-edge platforms like Chromium, Visium,..

IDEAYA Biosciences, Inc. (IDYA): Analyst Ratings Suggest a 42.69% Potential Upside for This Biotech Innovator

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) has captured the attention of investors in the biotechnology sector with its promising pipeline of targeted therapeutics and strategic partnerships. As a precision medicine oncology..

MannKind Corporation (MNKD) Investor Outlook: Exploring an 83% Potential Upside and Promising Biopharmaceutical Developments

MannKind Corporation (NASDAQ: MNKD) has been capturing the attention of investors with its robust potential for growth in the biopharmaceutical sector. With a market capitalization of $1.58 billion, MannKind’s focus..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Exploring a 90% Potential Upside in the Healthcare Sector

Dynavax Technologies Corporation (NASDAQ: DVAX) presents a compelling opportunity for investors intrigued by the healthcare sector’s potential. With a market capitalization of $1.34 billion, this Emeryville, California-based biopharmaceutical company is..

Arcellx, Inc. (ACLX) Stock Analysis: A Biotech Gem with 50% Upside Potential

Arcellx, Inc. (NASDAQ: ACLX), a pioneering player in the biotechnology sector, is drawing significant attention from investors, thanks to its promising pipeline of immunotherapy candidates and a substantial 50.91% potential..

Celldex Therapeutics, Inc. (CLDX) Investor Outlook: Exploring a Potential 101.91% Upside

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a biopharmaceutical company rooted in the biotechnology sector, is creating a buzz with its innovative therapeutic antibody developments aimed at treating severe inflammatory, allergic, and..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Envisioning a 256.99% Upside in Biotech Innovation

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) presents a compelling opportunity for individual investors navigating the dynamic biopharmaceutical sector. With a market capitalization of $793.75 million, this San Diego-based company is making..

GeneDx Holdings Corp. (WGS) Stock Analysis: A Diagnostic Powerhouse with Robust Revenue Growth

GeneDx Holdings Corp. (WGS), a key player in the healthcare sector, has been making waves in the diagnostics and research industry. With a market capitalization of $4.66 billion, GeneDx stands..

Artivion, Inc. (AORT) Stock Analysis: A Look at Its 12.89% Potential Upside in the Healthcare Sector

Artivion, Inc. (NASDAQ: AORT) has recently caught the attention of investors, thanks to its promising 12.89% potential upside. The Georgia-based medical device company has been making waves in the healthcare..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a 30.97% Potential Upside in the Healthcare Sector

LifeStance Health Group, Inc. (NASDAQ: LFST) is making significant strides in the healthcare sector, focusing on mental health services across the United States. With a market capitalization of $2.52 billion,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds